These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 37033)

  • 21. alpha-Amanitin prevents the positive inotropic effect of cardiac glycosides in-vitro.
    Bazzani C; Arletti R; Bertolini A
    J Pharm Pharmacol; 1983 Aug; 35(8):541-2. PubMed ID: 6137549
    [No Abstract]   [Full Text] [Related]  

  • 22. The influence of cardiac glycosides on membrane permeability in guinea-pig atrial tissue, determined by means of 86Rb.
    van Zwieten PA
    J Pharm Pharmacol; 1968 Sep; 20(9):731-3. PubMed ID: 4386388
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparative studies of some semisynthetic K-strophanthins with natural cardiac glycosides.
    Tawfik H; Fox AA; Greeff K
    Biochem Pharmacol; 1985 Jul; 34(14):2541-7. PubMed ID: 2990491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of inotropically active drugs on isolated papillary muscle].
    Reiter M
    Arzneimittelforschung; 1967 Oct; 17(10):1249-53. PubMed ID: 5632870
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of the cardiotonic response of ouabain, androstan-3-one, 16-dehydroprogesterone, and conjugated estrogens.
    Woods A; Martinez TT
    Proc West Pharmacol Soc; 1991; 34():113-5. PubMed ID: 1664956
    [No Abstract]   [Full Text] [Related]  

  • 26. Inotropic action, myocardial uptake and subcellular distribution of ouabain, digoxin and digitoxin in isolated rat hearts.
    Fricke U; Hollborn U; Klaus W
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 288(2-3):195-214. PubMed ID: 1161045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A pharmacological approach to the mode of digitalis action.
    Godfraind T
    Verh K Vlaam Acad Geneeskd Belg; 1969; 31(5):315-54. PubMed ID: 4914642
    [No Abstract]   [Full Text] [Related]  

  • 28. Cardiac glycosides decrease prostate specific antigen expression by down-regulation of prostate derived Ets factor.
    Juang HH; Lin YF; Chang PL; Tsui KH
    J Urol; 2010 Nov; 184(5):2158-64. PubMed ID: 20850842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of K+ on the interaction between cardiac glycosides and Na,K-ATPase.
    Akera T; Ng YC; Shieh IS; Bero E; Brody TM; Braselton WE
    Eur J Pharmacol; 1985 May; 111(2):147-57. PubMed ID: 2990948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac glycosides in the defensive secretion of chrysomelid beetles: evidence for their production by the insects.
    Pasteels JM; Daloze D
    Science; 1977 Jul; 197(4298):70-2. PubMed ID: 867051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The biphasic action of cardiac glycosides on the Na+, K+-pump and its relevance in the treatment of heart failure.
    Godfraind T
    Eur Heart J; 1982 Dec; 3 Suppl D():53-7. PubMed ID: 6297911
    [No Abstract]   [Full Text] [Related]  

  • 32. Therapeutic range of cardiac glycosides.
    Haustein KO
    Basic Res Cardiol; 1984; 79 Suppl():147-53. PubMed ID: 6331374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of DPI 201-106 with cardiac glycosides.
    Scholtysik G; Salzmann R; Gerber W
    J Cardiovasc Pharmacol; 1989 Feb; 13(2):342-7. PubMed ID: 2468968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. (Na+, K+)-ATPase in the myocardium.
    Gibson K
    Acta Cardiol; 1973; ():Suppl 17:41-51. PubMed ID: 4271961
    [No Abstract]   [Full Text] [Related]  

  • 35. [Drug interactions between cardiac glycosides and beta-sympathomimetics].
    Greeff K; Köhler E; Fortmüller HW; Schmidt R
    Arzneimittelforschung; 1973 Jun; 23(6):759-64. PubMed ID: 4740757
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacokinetics of tritiated ouabain, digoxin and digitoxin in guinea-pigs.
    Proppe D
    Clin Exp Pharmacol Physiol; 1975; 2(6):489-502. PubMed ID: 1236603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac glycosides with non-rotating steroid to sugar linkages: tools for the study of digitalis structure-activity relationships.
    Brown L; Thomas R; Watson T
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Jan; 332(1):98-102. PubMed ID: 3951571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological investigations on asclepin--a new cardenolide from Asclepius curassavica. Part I: Cardiotonic activity and acute toxicity.
    Patnaik GK; Dhawan BN
    Arzneimittelforschung; 1978; 28(7):1095-9. PubMed ID: 114186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of peripheral blood mononuclear cell proliferation by cardiac glycosides.
    Gentile DA; Henry J; Katz AJ; Skoner DP
    Ann Allergy Asthma Immunol; 1997 May; 78(5):466-72. PubMed ID: 9164359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Phytotherapeutic aspects of diseases of the circulatory system. III. Cardiotonic and cardiotoxic effects of hyrcanoside and deglucohyrcanoside isolated from Coronilla varia L].
    Slavík J; Zácková P; Michlová J; Opletal L; Sovová M
    Ceska Slov Farm; 1994 Nov; 43(6):298-302. PubMed ID: 7812688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.